Vitrafy enters a partnership with Vitalant Innovation Center
Filed with ASX · · 3 pages · English
Summary by 6ix AI
Vitrafy Life Sciences Ltd announces a partnership with Vitalant Innovation Center to develop a cryopreservation ecosystem for red blood cells. This partnership aims to address the urgent need for new technologies as existing methods for preserving red blood cells are being phased out.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Vitrafy Life Sciences Ltd. on 6ix
In the deck
Earlier from Vitrafy Life Sciences
- Phase 2 USAISR Platelet Results Investor Presentation
- Final US Army Phase 2 Platelet Results
- Q3 FY26 Quarterly Activities Report and Appendix 4C
- USAISR Completes Phase 2 Platelet Study
- FY26 Half Year Results Presentation
Later from Vitrafy Life Sciences
- Trading Halt
- Vitrafy Equity Raising Presentation
- Vitrafy Placement Completion and SPP Announcement
- Vitrafy Share Purchase Plan Opens - SPP Offer Booklet
- Vitrafy enters a partnership with Hoxworth Blood Center
Follow Vitrafy Life Sciences into a list and get an email when it puts out news.
Follow Vitrafy Life Sciences